Lentiviral Vector Development and Manufacturing Services
We help our partners turn their vision for future therapies into product realities using world-class experience to develop highly optimized Lentiviral vector-based medicines.
Escape the orbit of legacy CDMOs.
LENTIVERSE™ is the next frontier of lentiviral vector platforms engineered by the pioneers of cell and gene therapy to make development faster, clearer, and accessible to every innovator.
Enter the LENTIVERSE™.
Step through the airlock to a transparent, scalable world of lentiviral vector innovation.
- End-to-end platform-based vector engineering with CGMP execution in mind
- Transparent timelines and fast iteration cycles from RUO to CGMP
- Streamlined low-cost CGMP vector manufacturing approach
- Platform designed by the team behind the first lentiviral CAR-T to reach patients
- Royalty-free, fully characterized CGMP-ready lentiviral vectors
- Streamlined protocols, reagents, and process workflows for decentralized generic CAR-T manufacturing
- Optimized Anti-CD19 and anti-BCMA CAR constructs available
- Built-in documentation to simplify regulatory filings
Our Development Services
Lentiviral Vector Design & Optimization
We combine proprietary algorithms with deep expertise to design and optimize lentiviral vectors that align with your therapeutic goals, improving expression, potency, and production efficiency.
Preclinical Lentiviral Vector Production
We offer fast, reliable production of pre-clinical vectors to support in vitro and in vivo studies, ensuring a smooth transition to CGMP manufacturing when you're ready.
Custom Support
Our Custom Support services bridge the gap between development and commercialization, providing tailored assay development, expert regulatory guidance, and comprehensive process characterization and validation to prepare your therapy for BLA submission and a successful commercial launch.
Assay Development
Custom assay development services to test for parameters that are specific to your vector or CAR-T cell product
Regulatory Support
Regulatory support for clinical development and commercialization
Pre-Commercial Support
Our experienced team provides comprehensive process characterization and validation to ensure your therapy is fully prepared for BLA submission and commercial launch.
Regulatory Support
Our team also offers training, and comprehensive regulatory strategy and support to guide you through clinical development and commercialization with confidence and compliance.
Additional Training & Regulatory Support
- CAR-T cell manufacturing procedure
- Testing of CAR-T cells for use in the clinic
- Regulatory Support Services
Regulatory Strategy
- Regulatory Meetings
- Regulatory Submissions
- BLA Strategy
Our Manufacturing Services
GMP Lentiviral Vector Manufacturing
Our CGMP manufacturing services produce high-titer, clinical-grade lentiviral vectors using a scalable, chemically defined, serum-free suspension process to support regulatory approval and commercialization.
Commercial Vector Production
We deliver commercial-grade CGMP vector manufacturing and ongoing support to seamlessly transition your product from clinical development to full commercialization.
Cell Manufacturing Facility Support
We provide expert support for CGMP CAR-T cell manufacturing within both existing cleanroom infrastructures and modular cleanroom facilities to ensure operational readiness and compliance.
Connect with Our Team of Experts
Whether you’re exploring a new gene therapy or need a trusted partner for lentiviral vector design and manufacturing, we’re here to help. Contact us today to discuss your project and learn how Vector BioMed can support your path from concept to clinic.